Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Motor Activity 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammatory Breast Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Therapeutics 2Specimen Handling 2Early Intervention, Educational 2pegfilgrastim 1cediranib 1X-Rays 1Palliative Care 1Neoadjuvant Therapy 1Methods 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Indocyanine Green 1Hypnosis 1High-Energy Shock Waves 1Filgrastim 1Exercise Test 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Clostridium perfringens epsilon-toxin 1Analgesia 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Inflammatory Breast Neoplasms × Clostridium perfringens epsilon-toxin × Clear all
NCT07474090 2026-06-01

STEPS-BC

Wake Forest University Health Sciences

Phase NA Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡